STOCK TITAN

RAPT Therapeutics, Inc. (RAPT) Net Income by Year

RAPT

RAPT Therapeutics, Inc. reported a net loss of $129.9M in fiscal year 2024. This represents a decrease of 11.2% from the prior fiscal year. The table below carries 7 fiscal years, from 2018 to 2024, and the quarters RAPT Therapeutics, Inc. has filed alongside them.

FY2024 annual
Net Income -$129.9M
YoY -11.2%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RAPT Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Net Income-$129.9M-11.2%-$116.8M-39.3%-$83.8M-21.1%-$69.2M-30.8%-$52.9M-23.0%-$43.0M-19.0%-$36.1M

RAPT Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Net Income-$17.6M+4.6%-$17.6M+36.2%-$17.2M+43.8%N/A-$18.4M+41.2%-$27.7M-9.4%-$30.5M-4.3%N/A-$31.4M-47.7%-$25.3M-31.8%-$29.3M-43.0%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More RAPT Therapeutics, Inc. financials

Frequently Asked Questions

What was RAPT Therapeutics, Inc.'s net income in fiscal year 2024?

RAPT Therapeutics, Inc. reported a net loss of $129.9M in fiscal year 2024.

How fast is RAPT Therapeutics, Inc.'s net income growing?

RAPT Therapeutics, Inc. (RAPT) net income fell by 11.2% year over year, from -$116.8M to -$129.9M in fiscal year 2024.

How has RAPT Therapeutics, Inc.'s net income changed over the years?

Across the 7 fiscal years this page covers, RAPT Therapeutics, Inc. (RAPT) net income went from -$36.1M in fiscal year 2018 to -$129.9M in fiscal year 2024.

RAPT Therapeutics, Inc. (RAPT) reported -$17.6M in net income in Q3 2025. This represents an increase of 4.6% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what RAPT Therapeutics, Inc. (RAPT) reported on that line in every period on record.